C02AC05 • moxonidine • Cardiovascular system | Antiadrenergic agents, centrally acting | Imidazoline receptor agonists
Moxonidine is an antihypertensive medication used for the treatment of essential hypertension. It works by stimulating imidazoline receptors in the brainstem, leading to reduced sympathetic activity and, consequently, lower blood pressure.
The medication is taken orally, usually once daily, with the dose adjusted based on the patient's response. Common side effects include dry mouth, fatigue, dizziness, and drowsiness.
Moxonidine is contraindicated in patients with severe renal impairment, severe bradycardia, or hypersensitivity to the active substance. Its use also requires caution in patients with heart failure.
This medication is an effective option for managing hypertension, helping to reduce the risk of cardiovascular complications.
Substance: moxonidine
Date of last drug list: 01-05-2026
Commercial code: W62333003
Concentration: 0.4mg
Pharmaceutical form: film-coated tablets
Quantity: 28
Product type: original
Price: 41.34 RON
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.
Manufacturer: MYLAN LABORATORIES SAS - FRANTA
Holder: MYLAN HEALTHCARE GMBH - GERMANIA
Number: 5992/2013/03
Shelf life: 3 years
Price
Copayment
Patient
41.34 RON
20.67 RON
20.67 RON